Implications for the Multi-Disciplinary Management of Children With Craniofrontonasal Syndrome

Sophie Dupré1,2, Helen Care2, Zoe Gordon3

  • 1Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.

Insights

Craniofrontonasal syndrome (CFNS) linked to EFNB1 mutations often causes speech, language, and cognitive delays in females. Comprehensive multidisciplinary care is crucial for managing these complex neurodevelopmental challenges.

Area of Science:

  • Genetics
  • Pediatrics
  • Neurodevelopmental Disorders

Background:

  • Craniofrontonasal syndrome (CFNS) is a rare genetic disorder.
  • It is primarily associated with mutations in the EFNB1 gene.
  • CFNS presents with a range of craniofacial abnormalities and potential neurodevelopmental issues.

Purpose of the Study:

  • To evaluate the genetic and phenotypic characteristics of female patients with CFNS.
  • To assess the neurodevelopmental outcomes, including speech, language, and cognition, in relation to genotype.
  • To determine the implications for multidisciplinary management.

Main Methods:

  • Retrospective study of 25 female patients with EFNB1 mutations.
  • Review of medical records for genetic and phenotypic data.
  • Analysis of neurodevelopmental assessments (speech, language, cognition, IQ) and educational support needs.

Main Results:

  • Variable speech, language, and cognitive difficulties were observed, with high percentages experiencing expressive language (88%) and receptive language (57%) issues.
  • Cognitive assessments showed a variable IQ range (69-100).
  • 41% of patients required additional educational support, highlighting the complexity of CFNS.

Conclusions:

  • EFNB1 mutations in CFNS are associated with significant neurodevelopmental challenges.
  • Multidisciplinary team involvement is essential for comprehensive patient care.
  • Long-term follow-up is critical for managing the multifactorial presentation of CFNS.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
376